These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32377671)

  • 1. Initiation of Transdermal Fentanyl Among US Commercially Insured Patients Between 2007 and 2015.
    Costantino RC; Gressler LE; Onukwugha E; McPherson ML; Fudin J; Villalonga-Olives E; Slejko JF
    Pain Med; 2020 Oct; 21(10):2229-2236. PubMed ID: 32377671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Opioid Rotation Ratio From Transdermal Fentanyl to "Strong" Opioids in Patients With Cancer Pain.
    Reddy A; Yennurajalingam S; Reddy S; Wu J; Liu D; Dev R; Bruera E
    J Pain Symptom Manage; 2016 Jun; 51(6):1040-5. PubMed ID: 26826675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.
    Reddy A; Tayjasanant S; Haider A; Heung Y; Wu J; Liu D; Yennurajalingam S; Reddy S; de la Cruz M; Rodriguez EM; Waletich J; Vidal M; Arthur J; Holmes C; Tallie K; Wong A; Dev R; Williams J; Bruera E
    Cancer; 2016 Jan; 122(1):149-56. PubMed ID: 26451687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of low-dose matrix-type transdermal fentanyl applied for opioid initiation].
    Yamaguchi Y; Kagawa Y; Yoneta E; Kunimori K
    Gan To Kagaku Ryoho; 2012 May; 39(5):765-8. PubMed ID: 22584328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Analgesic Efficacy and Safety of Low-Dose Transdermal Fentanyl and Oral Oxycodone in Opioid-Naïve Patients with Cancer Pain.
    Kawana M; Miyasato A; Funato M; Nagatani K; Suzuki N; Onoda C; Fujimoto H; Ohno R; Kusakabe A; Kiribayashi M; Nakamura K; Kondo M; Ozeki A; Okamoto K; Kokubun H
    Biol Pharm Bull; 2023; 46(10):1444-1450. PubMed ID: 37779046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of Transdermal Fentanyl in a Hospital].
    Sako A; Yoshikawa Y; Kikuchi N; Watanabe A; Yoshida S
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):341-4. PubMed ID: 27067851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System.
    Larochelle MR; Cocoros NM; Popovic J; Dee EC; Kornegay C; Ju J; Racoosin JA
    J Opioid Manag; 2017; 13(5):315-327. PubMed ID: 29199397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why are US military personnel prescribed transdermal fentanyl patches?
    Murray H; Gregoriou AN; Lepore A; Booth GJ; Goldman AH; Allen ML; Balazs GC
    BMJ Mil Health; 2023 Aug; 169(4):335-339. PubMed ID: 34625516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe pain.
    Kang JH; Oh SY; Song SY; Lee HY; Kim JH; Lee KE; Lee HR; Hwang IG; Park SH; Kim WS; Park YS; Park K
    Korean J Intern Med; 2015 Jan; 30(1):88-95. PubMed ID: 25589840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of transdermal fentanyl initiation in Australian clinical practice.
    Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L
    Eur J Clin Pharmacol; 2019 Mar; 75(3):401-408. PubMed ID: 30392109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl.
    Moryl N; Bokhari A; Griffo Y; Hadler R; Koranteng L; Filkins A; Zheng T; Horn SD; Inturrisi CE
    Cancer Med; 2019 Dec; 8(18):7516-7522. PubMed ID: 31568684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiaries.
    Rigler SK; Shireman TI; Kallenbach L
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):91-9. PubMed ID: 17719511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain.
    Allan L; Richarz U; Simpson K; Slappendel R
    Spine (Phila Pa 1976); 2005 Nov; 30(22):2484-90. PubMed ID: 16284584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of transdermal fentanyl patches for opioid initiation in patients with gastrointestinal obstruction].
    Miyoshi T; Yamauchi H; Misumi N; Goto T; Kai S; Yoshida E; Nishino T; Hasuo Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1401-5. PubMed ID: 25434443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan].
    Hashizume T; Tomiyasu S; Yomiya K; Yoshimoto T; Harada A; Matoba M;
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):897-902. PubMed ID: 17570968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Reports of Transdermal Fentanyl Patch Administration Difficulties in Cancer Patients with Excess Sweating.
    Ishii H; Kokubun H; Tabata KI; Kanai A
    J Pain Palliat Care Pharmacother; 2023 Mar; 37(1):72-77. PubMed ID: 36378038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
    Koltzenburg M; Pokorny R; Gasser UE; Richarz U
    Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control.
    Pavelka K; Le Loet X; Bjorneboe O; Herrero-Beaumont G; Richarz U
    Curr Med Res Opin; 2004 Dec; 20(12):1967-77. PubMed ID: 15701214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.